Article Text

Download PDFPDF
Can we predict the development of haemolytic uraemic syndrome in the early stage of Escherichia coli O157 infection?
  1. Manohara Joishy,
  2. Praveen Jauhari,
  3. Ann A Mathew,
  4. T Rangarajan
  1. Prince Charles Hospital, Merthyr Tydfil, UK
  1. Manohara Joishy, Department of Paediatrics, Prince Charles Hospital, Merthyr Tydfil, CF47 9DT, UK; manoharj28{at}yahoo.co.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Verocytotoxin-producing Escherichia coli (E coli) 0157 is associated with a clinical spectrum of conditions including an asymptomatic infection, non-bloody diarrhoea, haemorrhagic colitis and, in up to 9% of patients, haemolytic uraemic syndrome (HUS).1 2 HUS has high morbidity and mortality.3 4 Identification of risk factors that could determine the development of HUS at an early stage of E coli 0157 infection would be very helpful in the management of these children. Leucocytosis is reported to be a reliable early risk factor for predicting progression to HUS.5

We …

View Full Text

Footnotes

  • Competing interests: None.